NEWS
View news from our Featured Companies.
GSE Systems Reports Second Quarter 2024 Financial Results
COLUMBIA, Md., Aug. 14, 2024 -- GSE Systems, Inc. ("GSE Solutions", "GSE", or "the Company") (Nasdaq: GVP), a leader in advanced engineering and workforce solutions that support the future of clean energy production and decarbonization initiatives of the nuclear power...
Scientific Industries to Host Second Quarter 2024 Financial Results Investor Call on August 15, 2024
Investor Call to be held at 11:00 AM Eastern Time BOHEMIA, NY / August 14, 2024 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced today it plans file the Form 10Q on...
Cadrenal Therapeutics to Present at Upcoming Investor Conferences
PONTE VEDRA, Fla., Aug. 14, 2024 -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage, next-generation Vitamin K Antagonist (VKA) oral and reversible anticoagulant (blood thinner) designed to prevent heart...
INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA
SARASOTA, Fla., Aug. 14, 2024 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment and acquisition of fertility clinics, and with the...
Precision Optics Announces Pricing of $1.4 Million Registered Direct Offering of Common Stock
GARDNER, Mass., Aug. 14, 2024 -- Precision Optics Corporation, Inc. (NASDAQ: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that it has entered into securities purchase...
Reviva Reports Second Quarter 2024 Financial Results and Recent Business Highlights
- Topline data from 1-year open-label extension (OLE) trial expected Q4 2024 - - Registrational RECOVER-2 trial in schizophrenia expected to initiate Q3 2024; topline data expected Q4 2025 - - European patent granted covering brilaroxazine use for treating pulmonary...
LiqTech International Announces Second Quarter 2024 Financial Results
BALLERUP, Denmark, Aug. 14, 2024 -- LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced its financial results for the second quarter of 2024. Q2...
Trinity Biotech Announces Q2 2024 Financial Results
-Q2, 2024 total revenues of $15.8 million grew +14% Y/Y and +7.7% Q/Q based on strong demand and output in the TrinScreen HIV business- -Point-of-Care product revenue of $4.6 million grew 119% Y/Y and +53% Q/Q- -Reiterating guidance to achieve approximately $20...
PolyPid Provides Corporate Update and Reports Second Quarter 2024 Financial Results
Approximately 320 Patients Enrolled in Ongoing SHIELD II Phase 3 Trial of D-PLEX100 for the Prevention of Abdominal Colorectal Surgical Site Infections Unblinded Interim Analysis to be Conducted Once Approximately 400 Patients Complete Their 30-Day Follow-up, Which is...
Trinity Biotech to Announce Q2 2024 Financial Results
Conference Call Scheduled for Wednesday, August 14, 2024 at 8:30 AM ETDUBLIN, Aug. 13, 2024 -- Trinity Biotech plc (Nasdaq: TRIB) (the "Company"), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including...
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024
PORTLAND, Maine, Aug. 13, 2024 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
LiqTech Obtains NSF Certification for Pool System Solution in U.S.
BALLERUP, Denmark, Aug. 13, 2024 -- LiqTech International, Inc. (NASDAQ: LIQT), a high-tech filtration technology company that manufactures and markets highly specialized filtration products and systems, today announced the receipt of NSF certification for their Aqua...
NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024
CARMEL, Ind., Aug. 13, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced medical...
LiqTech Receives Another US-Based Oil & Gas Produced Water Treatment Order from One of the World’s Leading Integrated Energy Companies
BALLERUP, Denmark, Aug. 12, 2024 -- LiqTech International, Inc. (NASDAQ: LIQT), a high-tech filtration technology company that manufactures and markets highly specialized filtration products and systems, today announced the receipt of an order from one of the world's...
NeurAxis Reports Second Quarter 2024 Financial Results
Conference call will be held today, Friday, August 9 at 9:00 am ETCarmel, Ind., Aug. 09, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating...
Kiora Pharmaceuticals Reports Second Quarter Results; Retinal Disease Drug Development Pipeline Advancing Toward Two Phase 2 Studies
Encinitas, California--(August 9, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") announces second quarter 2024 financial results and provides an update on its pipeline of therapeutics for the treatment of retinal diseases. During the...
SenesTech Announces Second Quarter 2024 Financial Results
Record Revenue and Margin Performance PHOENIX, Aug. 8, 2024 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth...
Jewett-Cameron Company Welcomes Mike Siuda as Vice President of Sales and Marketing
NORTH PLAINS, Ore., Aug. 8, 2024 -- Jewett-Cameron Company (NASDAQ: JCTCF) is pleased to announce the appointment of Mike Siuda as Vice President of Sales and Marketing. With a distinguished career spanning over three decades in the building products industry, Mike...
GSE Solutions to be Acquired by Pelican Energy Partners
COLUMBIA, Md., Aug. 8, 2024 -- GSE Solutions ("GSE Systems, Inc." or "GSE") (Nasdaq: GVP), a leader in advanced engineering solutions that supports the future of clean-energy production and decarbonization initiatives of the power industry, announced today that it has...
Mogo Reports Results for Q2 2024
Quarterly revenue of $17.6 million, up 10% year-over-year Adjusted EBITDA1 increased sequentially to $1.4 million in Q2 2024 Quarterly payments volume increased 12% year-over-year to $2.8 billion Ended Q2 with $41.5 million of cash, marketable securities &...
Registration is Now Open for Tribe Public’s Webinar Event “Diabetes Care Innovator Modular Medical Takes Next Steps” Featuring Modular Medical CEO on Friday, August 9, 2024
The global diabetes care market, valued at $18.9 billion in 2023, is projected to reach $35.8 billion by 2028The insulin pump segment is expected to grow from $5.26 billion to $21.65 billion by 2032Discover how Modular Medical is accelerating the development of...
InfuSystem Reports Second Quarter 2024 Financial Results
Record Net Revenues of $33.7 million Representing 6% Growth from the Prior Year Reaffirms Full-Year 2024 Guidance ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider,...
ChromaDex Corporation Reports Second Quarter 2024 Financial Results
Total net sales of $22.7 million, up 12% year-over-year, gross margin of 60.2%, lower operating expenses, resulting in approximately breakeven net loss and positive Adjusted EBITDA of $1.6 million for the three months ended June 30, 2024. LOS ANGELES - ChromaDex Corp....
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024
Conference Call Scheduled for Wednesday, August 14, 2024 at 9:00 AM ETPORTLAND, Maine, Aug. 07, 2024 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and...
Cadrenal Therapeutics Provides Second Quarter 2024 Corporate Update
PONTE VEDRA, Fla., Aug. 7, 2024 -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage, next-generation Vitamin K Antagonist (VKA) oral and reversible anticoagulant (blood thinner) designed to prevent heart...